Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether medical treatment for bladder outlet obstruction is effective in improvement of glomerular filtration rate and/or proteinuria.
Urodynamic parameters including maximal flow rate, compliance (infused volume gradient divided by bladder pressure gradient during cystometry), maximal detrusor pressure, bladder outlet obstruction index and Schäfer grade will be checked.
Estimated glomerular filtration rate and urinary protein to creatinine ratio will be checked.
International prostate symptom score will be checked.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Tamsulosin | Experimental | The dosage form of Tamsulosin is tablet, dosage is 0.2mg, frequency is once daily and duration is 6 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tamsulosin | Drug | Once Daily 0.2mg per oral for 6 months |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximal flow rate | This parameter can be obtained from urodynamic study. | 6 months |
| Maximal detrusor pressure | This parameter can be obtained from urodynamic study. | 6 months |
| Bladder outlet obstruction index | This parameter can be obtained from urodynamic study. | 6 months |
| schäfer grade | This parameter can be obtained from urodynamic study. | 6 months |
| Compliance | This parameter can be obtained from urodynamic study. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Estimated glomerular filtration rate | 6 months | |
| Urinary protein to creatinine ratio | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| International prostate symptom score | 6 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Seung-Ju Lee, MD, PhD | Contact | 82-31-249-8305 | lee.seungju@gmail.com | |
| Dong Sup Lee, MD, PhD | Contact | 82-31-249-8276 | lds@catholic.ac.kr |
| Name | Affiliation | Role |
|---|---|---|
| Seung-Ju Lee, MD, PhD | The Catholic University of Korea | Study Chair |
| Dong Sup Lee, MD, PhD | The Catholic University of Korea | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Vincent's Hospital | Suwon | Gyeonggi-do | 442-723 | South Korea |
Not provided
| ID | Term |
|---|---|
| D007676 | Kidney Failure, Chronic |
| D011470 | Prostatic Hyperplasia |
| ID | Term |
|---|---|
| D051436 | Renal Insufficiency, Chronic |
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077409 | Tamsulosin |
| ID | Term |
|---|---|
| D000096926 | Benzenesulfonamides |
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D052776 |
| Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D011469 | Prostatic Diseases |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D001555 |
| Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |